For interactive signal configurations, you can maintain a list of targeted medical events (TMEs) for each product. A TME is an adverse event that your organization wants to monitor closely for a particular product. For example, you might add Hepatic failure as a TME for Product A.
Before you begin, consider the following:
· You must have the Manage Signaling Terms permission to manage TMEs.
· The Data Configuration for 2D Runs specified for the signal configuration must be present and valid.
· The Event Variable for 2D Runs and Drug Variable for 2D Runs specified for the signal configuration must exist in the Data Configuration for 2D Runs.
· You define TMEs at the hierarchy level specified in the Event Variable for 2D Runs field for the signal configuration. For example, if the Event Variable for 2D Runs is (Event) PT, you define TMEs using preferred terms.
· You cannot add or delete a targeted medical event while a signal configuration refresh is in progress.
· You must refresh the signal configuration for your changes to take effect.
1. In the
left navigation pane, click the Signal Review
icon ().
2. (Optional) From the Products By drop-down list, select a product grouping, then select a card to filter the Products table.
3. Click the
product's Row Action
menu () and
select Manage Targeted Medical Events.
4. Add a TME for the product using one of the following methods:
· Select a saved list of values.
Note: To prevent spelling and capitalization errors, we recommend that you select rather than type values.
5. (Optional) Select the Validate list when saving checkbox.
If you select the checkbox, Empirica Signal checks whether the terms that you specified are in the source data. If the terms are not in the source data, an error message appears and the invalid terms are moved to the end of the list.
6. Click Save.
· The TMEs are saved and are applied when you refresh the signal configuration.
· In the Product-Event Combinations page, the TME column identifies product-event combinations that are associated with a TME.